You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for DIMETHYL SULFOXIDE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for DIMETHYL SULFOXIDE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial 154938_SIAL ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial 539503_ALDRICH ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial D2438_SIGMA ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial D2650_SIGMA ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial D4540_SIGMA ⤷  Start Trial
Sigma-Aldrich ⤷  Start Trial D8418_SIGMA ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk API Sources for Dimethyl Sulfoxide (DMSO)

Last updated: February 19, 2026

Dimethyl sulfoxide (DMSO) is a widely used solvent in pharmaceuticals, biotech, and chemical industries. It is a polar aprotic solvent with applications ranging from drug formulation to cryopreservation. Reliable sourcing of bulk API for DMSO involves manufacturers with proven purity standards, regulatory compliance, and capacity for high-volume supply.

Major API Manufacturers for DMSO

Company Name Country Approvals & Certifications Capacity & Volume Notes
Sigma-Aldrich (Merck) United States GMP-certified, ISO 9001, ISO 14001, cGMP 10+ tons/month Largest supplier with extensive catalog
Beijing Shuanghe Chemical China GMP certification, CGMP compliant manufacturing Data not publicly available Significant supplier in Asia; quality varies
TCI Chemicals Japan ISO 9001, ISO 14001, cGMP-certified manufacturing High-volume capacity Focused on pharmaceutical-grade API
Carl Roth GmbH + Co. KG Germany ISO 9001, pharmaceutical-grade purity Moderate Supplies research and pilot-scale quantities
Sigma-Aldrich (Merck) United States GMP-certified, high purity API Extensive supply Global distribution network

International Regulatory & Quality Standards

  • U.S. Pharmacopeia (USP): DMSO for pharmaceutical use complies with USP standards, guaranteeing purity levels suitable for human or animal use.
  • European Pharmacopoeia (Ph. Eur.): Specifies vetting for high-quality DMSO, free from residual impurities.
  • cGMP Compliance: Critical for pharmaceutical applications, ensuring batch-to-batch consistency, purity, and safety.
  • ISO Certifications: ISO 9001 for quality management systems and ISO 14001 for environmental management.

Sourcing Considerations

  • Purity Grade: Pharmaceutical-grade (USP, EP) must have purity levels exceeding 99.9%, with specific impurity limits.
  • Batch Consistency: Suppliers should demonstrate consistent manufacturing output, verified through lot-release testing.
  • Regulatory Approvals: For human or veterinary applications, suppliers must have approvals from relevant authorities (FDA, EMA, etc.).
  • Capacity & Lead Time: High-volume demand requires suppliers with scalable production, and lead times must be factored into procurement strategies.
  • Supply Chain: Geographic location impacts shipping times and costs; proximity to manufacturing sites may influence logistics.

Market Dynamics and Trends

  • Increased Demand: Due to expanding use in cryopreservation, drug delivery systems, and research.
  • Supply Chain Disruptions: Originating from raw material shortages, geopolitical tensions, or regulatory changes.
  • Regulatory Stringency: Moves toward stricter quality standards have favored established international suppliers over smaller, less-regulated producers.
  • Price Volatility: Fluctuates with raw material costs, demand surges, and currency exchange rates.

Regulatory & Import/Export Policies

  • Export Controls: Some countries impose restrictions on chemical exports, influencing global availability.
  • Import Licenses: Buyers must verify country-specific import licenses to import pharmaceutical-grade DMSO.
  • Customs Clearance: Proper documentation, including MSDS, COA, and regulatory approvals, accelerates import processes.

Summary of Key Manufacturing Regions

Region Notable Features Market Share Estimate (2018-2023) Comment
North America Advanced manufacturing, strict regulatory environment 45% Largest, with high-quality standards
Europe High-quality standards, R&D focus, certified facilities 25% Strong in pharmaceutical-grade supply
Asia-Pacific Cost-sensitive, high-volume production, increasing reform adherence 30% Growing presence, variable quality

Conclusion

Sourcing bulk API for DMSO requires evaluating manufacturer certifications, quality standards, capacity, and regulatory compliance. Leading global suppliers like Sigma-Aldrich and TCI Chemicals dominate the market, with supply chain reliability and regulatory adherence as primary selection criteria.

Key Takeaways

  • The primary suppliers are Sigma-Aldrich (Merck), TCI Chemicals, and Beijing Shuanghe Chemical.
  • Pharmaceutical-grade DMSO must meet USP or Ph. Eur. standards with high purity and consistent quality.
  • Capacity for high-volume supply and compliance with cGMP are critical for industrial or clinical applications.
  • Market trends indicate rising demand driven by biotech and cryopreservation industries.
  • Supply chain risks include raw material availability, geopolitical issues, and regulatory changes.

FAQs

1. What is the typical purity level required for pharmaceutical-grade DMSO?
Pharmaceutical-grade DMSO generally exceeds 99.9% purity, with impurity levels strictly regulated to ensure safety and efficacy.

2. How do regional manufacturing standards influence API quality?
Manufacturers in Europe and North America typically adhere to stricter cGMP standards, resulting in more consistent quality compared to some Asian producers, although many meet both regional and international standards.

3. What are the key factors to consider when sourcing bulk DMSO for clinical use?
Regulatory approval, batch certification, purity, manufacturing compliance, and capacity for supply.

4. Are there significant differences in price between suppliers?
Yes, prices vary based on purity grade, volume, supplier location, and contract terms, with European and North American suppliers generally commanding higher prices.

5. What are potential risks in the global supply chain for DMSO?
Raw material shortages, geopolitical restrictions, export controls, regulatory enforcement, and transportation disruptions.


References

[1] U.S. Pharmacopeia. (2022). USP Monographs on DMSO. Retrieved from https://www.usp.org

[2] European Pharmacopoeia. (2022). DMSO Monograph. Retrieved from https://www.edqm.eu

[3] MarketWatch. (2023). Global DMSO Market Size, Share & Trends. Retrieved from https://www.marketwatch.com

[4] International Organization for Standardization (ISO). (2022). ISO Certifications for Chemical Manufacturers. Retrieved from https://www.iso.org

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.